Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia

Detalles Bibliográficos
Autores principales: Chandrakala, S., Toshniwal, Manoj, Halvawala, Mitesh, Padwal, Namita, Sidharthan, Neeraj, Malhotra, Pankaj, Prashantha, B., Ballikar, Riya, Shah, Sandip, Apte, Shashikant, Viswanathan, T. Kasi, Ramanan, Vijay, Sharma, Akhilesh, Pawar, Dattatray, Pawar, Roshan, Shahavi, Vinayaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247629/
https://www.ncbi.nlm.nih.gov/pubmed/37304472
http://dx.doi.org/10.1007/s12288-023-01635-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247629/
https://www.ncbi.nlm.nih.gov/pubmed/37304472
http://dx.doi.org/10.1007/s12288-023-01635-4

Ejemplares similares